Anti-Atherogenic Activity of Ethanolic Fraction of Terminalia arjuna Bark on Hypercholesterolemic Rabbits
Table 2
Serum lipid profile and atherogenic index.
No. of days
Parameters
Control
D. Control
Std
EtOH 100 (mg kg−1)
EtOH 200 (mg kg−1)
Baseline
TC (mg dl−1)
54.02 ± 1.99
53.42 ± 3.66
55.84 ± 3.44
54.91 ± 4.50
54.38 ± 3.04
HDL (mg dl−1)
31.69 ± 1.95
30.03 ± 1.15
29.47 ± 1.50
26.62 ± 1.88
30.62 ± 2.16
LDL (mg dl−1)
7.50 ± 3.41
5.86 ± 3.89
10.93 ± 3.62
14.13 ± 4.54
9.64 ± 2.06
VLDL (mg dl−1)
14.83 ± 0.73
17.53 ± 0.48
15.44 ± 0.77
14.16 ± 0.66
14.12 ± 0.82
TG (mg dl−1)
74.15 ± 3.65
87.63 ± 2.42
77.18 ± 3.85
70.80 ± 3.31
70.62 ± 4.11
14 days
TC (mg dl−1)
63.63 ± 4.95
143.36 ± 8.01
71.82 ± 5.30
122.90 ± 8.18
108.76 ± 6.67
HDL (mg dl−1)
35.13 ± 1.98
34.75 ± 4.27
38.25 ± 4.35
38.44 ± 1.62
40.50 ± 2.65
LDL (mg dl−1)
7.09 ± 7.09
15.86 ± 12.92
6.14 ± 5.68
15.73 ± 4.36
13.69 ± 9.78
VLDL (mg dl−1)
35.59 ± 1.66
92.75 ± 12.67
39.70 ± 1.62
68.73 ± 3.90
51.95 ± 5.70
TG (mg dl−1)
177.93 ± 8.29
463.77 ± 63.37
198.50 ± 8.10
373.63 ± 19.48
299.76 ± 28.49
36 days
TC (mg dl−1)
254.86 ± 2.18
552.55 ± 42.00
269.83 ± 11.45
399.96 ± 41.61
359.65 ± 41.08
HDL (mg dl−1)
33.94 ± 2.21
32.94 ± 3.56
38.00 ± 5.89
34.00 ± 4.40
37.91 ± 1.64
LDL (mg dl−1)
170.49 ± 5.41
347.48 ± 32.80
175.53 ± 9.05
177.33 ± 39.96
208.64 ± 42.99
VLDL (mg dl−1)
50.43 ± 6.57
172.13 ± 12.35
56.29 ± 1.79
138.63 ± 3.72
113.10 ± 6.71
TG (mg dl−1)
252.15 ± 32.84
860.65 ± 61.77
281.46 ± 8.96
663.16 ± 18.58
539.50 ± 33.55
72 days
TC (mg dl−1)
353.78 ± 5.78
868.43 ± 47.98
384.69 ± 4.94
604.58 ± 27.42
543.47 ± 53.91
HDL (mg dl−1)
34.25 ± 1.71
30.00 ± 1.15
41.75 ± 4.92
35.25 ± 2.99
38.58 ± 4.38
LDL (mg dl−1)
252.41 ± 7.47
582.44 ± 52.37
267.06 ± 2.23
489.17 ± 33.85
348.02 ± 63.85
VLDL (mg dl−1)
67.11 ± 3.45
255.98 ± 7.82
75.88 ± 2.25
180.16 ± 13.48
156.87 ± 9.58
TG (mg dl−1)
335.57 ± 17.27
1279.92 ± 39.09
379.38 ± 11.23
900.79 ± 67.40
704.36 ± 47.92
Atherogenic Index
10.32 ± 2.38
28.94 ± 2.55
9.21 ± 1.02
19.98 ± 4.18
14.08 ± 3.31
Values expressed are mean ± SD of four animals per group. statistical significance at P < .05 when compared with control, disease control, standard and treatment, respectively, on performing repeated measures ANOVA with Tukey’s multiple comparison post hoc test.